#Nosocomial #outbreak of #Lassa fever in Conakry, #Guinea, 2022, https://etidiohnew.blogspot.com/2026/04/nosocomial-outbreak-of-lassa-fever-in.html

The virus entry #inhibitor ARN-75039 provides therapeutic #protection against #Lassa virus infection in guinea pigs, https://etidiohnew.blogspot.com/2026/04/the-virus-entry-inhibitor-arn-75039.html

Post-discharge #sequelae of #Lassa fever #survivors in #Nigeria: an analysis of the LASCOPE prospective cohort, https://etidiohnew.blogspot.com/2026/03/post-discharge-sequelae-of-lassa-fever.html

#Lassa fever #symptomatology, viral dynamics, and host immune response (PREPARE): a prospective, observational cohort study in #Liberia, https://etidiohnew.blogspot.com/2026/01/lassa-fever-symptomatology-viral.html

#Serological evidence of concurrent #Lassa virus and #SARS-CoV-2 #exposure in #Ghana- a cross-sectional study, https://etidiohnew.blogspot.com/2025/12/serological-evidence-of-concurrent.html

Safety, tolerability, and immunogenicity of INO-4500, a synthetic #DNA-based #vaccine against #Lassa virus, in a phase 1b clinical trial in healthy Ghanaian adults, https://etidiohnew.blogspot.com/2025/11/safety-tolerability-and-immunogenicity.html

#Safety and Immunogenicity of an rVSV #Lassa Fever #Vaccine Candidate, https://etidiohnew.blogspot.com/2025/11/safety-and-immunogenicity-of-rvsv-lassa.html

#Lassa Virus #Infection of Primary #Human #Airway Epithelial Cells, https://etidiohnew.blogspot.com/2025/04/lassa-virus-infection-of-primary-human.html

Coadministration of #ribavirin and #arenaviral entry #inhibitor LHF-535 enhances antiviral benefit against authentic #Lassa virus, https://etidiohnew.blogspot.com/2025/04/coadministration-of-ribavirin-and.html